top of page

Andhra Pradesh: Nitrogen plants to produce O2

  • To ease pressure on oxygen supplies in the state, the Andhra Pradesh Pollution Control Board (APPCB) has granted permission to some companies in the state to use their existing nitrogen plants for the generation of medical oxygen.

  • The decision has been taken to cover the shortfall in the supply of medical oxygen for Covid-19 affected patients. APPCB chairman AK Parida said Aurobindo Pharma Limited, Deccan Fine Chemicals, MetrochemAPI Private Limited, and Mylan Laboratories Limited have been granted permission.

  • The companies have been permitted to use pressure swing adsorption (PSA) technology for the conversion process. The Central Pollution Control Board (CPCB) will be identifying vendors and providing technical support along with APPCB to undertake the task on a war footing.

  • Covid-19 hospitals identified by the state government will be getting the supply directly from these companies.

Here the list of Vizag industries allowed to produce O2:

Aurobindo Pharma, Deccan Fine Chemicals, Metrochem API, and Mylan Laboratories have been permitted to convert their nitrogen plants for medical oxygen generation.

  • Meanwhile, APPCB has directed all 240 hospitals providing emergency treatment to Covid-19 patients in the state to hand over Covid-19 biomedical waste to the Common Bio-Medical Waste Treatment Facility (CBMWTF) located in their respective districts.

  • Parida said hospitals have also been directed to register themselves using the CPCB mobile application and hand over the waste for disposal in a scientific manner to the CBMWTF.

  • He said instructions have been issued to identify one nodal person in each hospital who will hand over the waste and update the information on the app.

  • Municipal commissioners have been directed not to allow municipal workers to collect Covid-19 waste as poses a health hazard and may aid in spreading the virus, Parida said.

What do you think about Nitrogen plants producing O2, Do let us know in the Comments Below!

54 views0 comments


bottom of page